OLMA
Olema Pharmaceuticals, Inc. Common Stock
Healthcare •
Biotechnology •
stocks •
XNAS
• usd
$26.34
+$0.20
(+0.77%)
Loading...
SMA 20: -
SMA 50: -
SMA 200: -
| General | Valuation | Profitability | Financial Health | Trading | Ownership |
|---|---|---|---|---|---|
| Market Cap | $2.11B | EPS (ttm) | $-1.76 | Current Price | $26.34 |
| Enterprise Value | $1.48B | Forward EPS | $-2.31 | Previous Close | $26.14 |
| P/E Ratio | - | ROA | -34.41% | 52W High | $36.26 |
| Forward P/E | -11.40 | ROE | -59.23% | 52W Low | $2.86 |
| PEG Ratio | - | Gross Margin | - | 50 Day Avg | $27.37 |
| P/S Ratio | - | Operating Margin | - | 200 Day Avg | $11.70 |
| P/B Ratio | 5.88 | Profit Margin | - | Volume | 2.12M |
| EV/EBITDA | -9.28 | Current Ratio | 8.03 | Avg Volume | 3.82M |
| EV/Sales | - | Quick Ratio | 7.97 | Beta | 1.92 |
| Employees | 122.00 | Debt/Equity | 1.46 | Shares Outstanding | 80.16M |
| Sector | Healthcare | Total Debt | $4.48M | Float Shares | 50.03M |
| Industry | Biotechnology | Total Cash | $328.96M | Short Float | 12.31% |
| Optionable | - | Cash/Share | $4.79 | Short Ratio | 4.95 |
| Dividend Yield | - | Book Value/Share | $4.48 | % Held by Insiders | 2.16% |
| Target Price | $45.90 | Revenue (TTM) | - | % Held by Institutions | 88.44% |